File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s00066-020-01612-0
- Scopus: eid_2-s2.0-85084066116
- PMID: 32313964
- WOS: WOS:000527457200001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Toxicity outcome of endorectal brachytherapy boost in medically inoperable patients
Title | Toxicity outcome of endorectal brachytherapy boost in medically inoperable patients |
---|---|
Authors | |
Keywords | High dose rate endorectal brachytherapy Rectal cancer Medically inoperable Toxicity Rectal brachytherapy |
Issue Date | 2020 |
Publisher | Springer Medizin. The Journal's web site is located at http://www.springer.com/medicine/radiology/journal/66 |
Citation | Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik, 2020, v. 196 n. 11, p. 993-997 How to Cite? |
Abstract | Aim:
This communication reviews results and toxicity of image-guided high-dose-rate endorectal brachytherapy (HDREBT) boost after external beam radiotherapy (ERT) in medically inoperable patients with rectal cancer.
Materials and methods:
A total of 18 patients with rectal cancer and clinical stage T2-4N0‑2 treated with HDREBT boost after ERT were retrospectively reviewed.
Results:
Following treatment with a median total dose (EQD2, α/β = 10) of 66 Gy (range 48–92 Gy), the incidence of early and late rectal grade 3 toxicity was 11% and 19%, respectively. There was no correlation between the occurrence of acute and late toxicity.
Conclusion:
With proper technique, a combined approach using EBRT and HDREBT was associated with acceptable toxicity in medically inoperable rectal cancer patients. |
Persistent Identifier | http://hdl.handle.net/10722/282523 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.907 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chiang, CL | - |
dc.contributor.author | Lee, SF | - |
dc.contributor.author | Lee, VWY | - |
dc.contributor.author | Yeung, CSY | - |
dc.contributor.author | Cheung, SKT | - |
dc.contributor.author | Poon, MCM | - |
dc.contributor.author | Foo, DCC | - |
dc.contributor.author | Lo, SH | - |
dc.contributor.author | Lam, KO | - |
dc.contributor.author | Lee, FAS | - |
dc.contributor.author | Wong, FCS | - |
dc.contributor.author | Chan, MKH | - |
dc.date.accessioned | 2020-05-15T05:29:13Z | - |
dc.date.available | 2020-05-15T05:29:13Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik, 2020, v. 196 n. 11, p. 993-997 | - |
dc.identifier.issn | 0179-7158 | - |
dc.identifier.uri | http://hdl.handle.net/10722/282523 | - |
dc.description.abstract | Aim: This communication reviews results and toxicity of image-guided high-dose-rate endorectal brachytherapy (HDREBT) boost after external beam radiotherapy (ERT) in medically inoperable patients with rectal cancer. Materials and methods: A total of 18 patients with rectal cancer and clinical stage T2-4N0‑2 treated with HDREBT boost after ERT were retrospectively reviewed. Results: Following treatment with a median total dose (EQD2, α/β = 10) of 66 Gy (range 48–92 Gy), the incidence of early and late rectal grade 3 toxicity was 11% and 19%, respectively. There was no correlation between the occurrence of acute and late toxicity. Conclusion: With proper technique, a combined approach using EBRT and HDREBT was associated with acceptable toxicity in medically inoperable rectal cancer patients. | - |
dc.language | eng | - |
dc.publisher | Springer Medizin. The Journal's web site is located at http://www.springer.com/medicine/radiology/journal/66 | - |
dc.relation.ispartof | Strahlentherapie und Onkologie: Zeitschrift fuer Radiologie, Strahlenbiologie, Strahlenphysik | - |
dc.subject | High dose rate endorectal brachytherapy | - |
dc.subject | Rectal cancer | - |
dc.subject | Medically inoperable | - |
dc.subject | Toxicity | - |
dc.subject | Rectal brachytherapy | - |
dc.title | Toxicity outcome of endorectal brachytherapy boost in medically inoperable patients | - |
dc.type | Article | - |
dc.identifier.email | Chiang, CL: chiangcl@hku.hk | - |
dc.identifier.email | Lee, SF: leesf@hku.hk | - |
dc.identifier.email | Foo, DCC: ccfoo@hku.hk | - |
dc.identifier.email | Lo, SH: oswens@hku.hk | - |
dc.identifier.email | Lam, KO: lamkaon@hku.hk | - |
dc.identifier.authority | Chiang, CL=rp02241 | - |
dc.identifier.authority | Lee, SF=rp02863 | - |
dc.identifier.authority | Foo, DCC=rp01899 | - |
dc.identifier.authority | Lam, KO=rp01501 | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1007/s00066-020-01612-0 | - |
dc.identifier.pmid | 32313964 | - |
dc.identifier.scopus | eid_2-s2.0-85084066116 | - |
dc.identifier.hkuros | 309881 | - |
dc.identifier.volume | 196 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 993 | - |
dc.identifier.epage | 997 | - |
dc.identifier.isi | WOS:000527457200001 | - |
dc.publisher.place | Germany | - |
dc.identifier.issnl | 0179-7158 | - |